Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37
United States Fiscal year ends December CIK 0002023658 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Claire Mazumdar
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,080
$5.45
$38.61K
Claire Mazumdar
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,454
$3.79
$28.25K
Claire Mazumdar
16 Apr 2026
Chief Executive Officer
Exercised, kept
8,226
$4.44
$36.50K
David Raben
26 Dec 2025
Chief Medical Officer
Exercised, kept
19,789
$3.79
$75.00K
Ryan Cohlhepp
26 Dec 2025
President and COO
Exercised, kept
25,000
$4.44
$110.92K
Claire Mazumdar
16 Dec 2025
Chief Executive Officer
Exercised, kept
29,500
$5.45
$160.88K

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 54
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 496,312
History held since 16 Sep 2024